Reauthorization of Generic Drug User Fee Seen As A Win For Consumers

November 15, 2017

Starting in 2012, the Generic Drug User Fee Amendments helped increase the number of generic drug applications approved by the FDA. Having recently been reauthorized, the FDA looks forward to increasing the number of safe and affordable generic drugs available to American citizens…

[...]

Shabby Standards

July 25, 2008

Bryan A.  Liang, MD, PhD, JD 

Earlier this week, I talked about India's opposition to IMPACT's proposed definition of a counterfeit medicine.  Indian "experts" claimed it would hurt their generic drug industry's exports, and I asked just who these "experts" were protecting if the IMPACT's focus was only non-legitimate producers.  

[...]